Acotec Scientific Holdings Limited provided revenue guidance for the year ended December 31, 2021. For the period the Group expects to record: revenue of approximately RMB 300 million to RMB 303 million, representing an increase of approximately 54.7% to 56.2% as compared to that of the year ended December 31, 2020.
Acotec Scientific Holdings Limited
Equities
6669
KYG0096M1096
Medical Equipment, Supplies & Distribution
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
7.35 HKD | -1.61% |
|
-8.12% | -34.84% |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-34.84% | 300M | |
+75.69% | 12.57B | |
-20.94% | 7.63B | |
-3.93% | 5.84B | |
+8.16% | 5.16B | |
-17.25% | 4.75B | |
-12.24% | 4.17B | |
+16.22% | 4.16B | |
-8.64% | 3.37B | |
+27.53% | 2.07B |
- Stock Market
- Equities
- 6669 Stock
- News Acotec Scientific Holdings Limited
- Acotec Scientific Holdings Limited Provides Revenue Guidance for the Year Ended December 31, 2021